Sio Capital Management, LLC Viking Therapeutics, Inc. Transaction History

Sio Capital Management, LLC

$268 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.92 - $16.0 $735,407 - $1.08 Million	67,345 Added 12.76%	595,002 $6.59 Million
Q2 2023 Aug 14, 2023	BUY	$14.84 - $24.79 $4.12 Million - $6.88 Million	277,657 Added 111.06%	527,657 $8.55 Million
Q1 2023 May 12, 2023	BUY	$8.08 - $17.33 $2.02 Million - $4.33 Million	250,000 New	250,000 $4.16 Million
Q1 2022 May 16, 2022	BUY	$3.0 - $4.88 $1.02 Million - $1.65 Million	339,016 Added 51.3%	999,829 $3 Million
Q3 2021 Nov 15, 2021	BUY	$5.58 - $7.04 $228,964 - $288,872	41,033 Added 6.62%	660,813 $4.15 Million
Q2 2021 Aug 16, 2021	BUY	$5.19 - $6.73 $259,500 - $336,500	50,000 Added 8.78%	619,780 $3.71 Million
Q1 2021 May 14, 2021	SELL	$5.74 - $9.67 $229,600 - $386,800	-40,000 Reduced 6.56%	569,780 $3.6 Million
Q4 2020 Feb 16, 2021	SELL	$5.3 - $6.71 $530,000 - $671,000	-100,000 Reduced 14.09%	609,780 $3.43 Million
Q2 2020 Aug 14, 2020	SELL	$4.35 - $8.08 $184,705 - $343,084	-42,461 Reduced 5.64%	709,780 $5.12 Million
Q1 2020 May 15, 2020	BUY	$3.45 - $7.95 $71,718 - $165,264	20,788 Added 2.84%	752,241 $3.52 Million
Q4 2019 Feb 14, 2020	SELL	$6.38 - $8.73 $148,692 - $203,461	-23,306 Reduced 3.09%	731,453 $5.87 Million
Q2 2019 Aug 14, 2019	SELL	$7.67 - $10.63 $747,065 - $1.04 Million	-97,401 Reduced 11.43%	754,759 $6.26 Million
Q1 2019 May 15, 2019	BUY	$7.58 - $9.94 $1.63 Million - $2.14 Million	215,114 Added 33.77%	852,160 $8.47 Million
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $3.03 Million - $6.87 Million	423,794 Added 198.73%	637,046 $4.87 Million
Q3 2018 Nov 14, 2018	SELL	$9.7 - $19.65 $660,104 - $1.34 Million	-68,052 Reduced 24.19%	213,252 $3.72 Million
Q2 2018 Aug 14, 2018	SELL	$3.88 - $12.74 $3.86 Million - $12.7 Million	-995,541 Reduced 77.97%	281,304 $2.67 Million
Q1 2018 May 15, 2018	BUY	$4.11 - $6.93 $109,305 - $184,303	26,595 Added 2.13%	1,276,845 $5.58 Million
Q4 2017 Feb 14, 2018	BUY	$1.74 - $4.34 $2.18 Million - $5.43 Million	1,250,250	1,250,250 $5.08 Million

Others Institutions Holding VKTX

# of Institutions

442

Shares Held

63.3M

Call Options Held

6.23M

Put Options Held

2.97M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.83B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.

Account